Starlight Therapeutics
Focus: Starlight Therapeutics is a CNS-focused biotechnology company specializing in small molecule therapies for adult and pediatric brain tumors, operating from Plano, Texas since 2008. The company is positioned in the early-stage oncology/neurology space with a limited but targeted pipeline.
Profile data last refreshed 12h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Starlight Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Starlight Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Starlight Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Ductus Arteriosus Stent
Congenital Heart DiseaseSTAR-001
Glioblastoma (GBM)Clinical Trials (1)
Help build intelligence for Starlight Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.